Skip to Content
  1. Authors
  2. Shannon Zimmerman

Shannon Zimmerman

Shannon Zimmerman is a director, manager selection, for Morningstar Shannon Zimmerman is a director, manager selection, for Morningstar.

Latest

Biotech companies addressing unmet medical needs with novel treatments can be a great source of growth in a slow-growth environment, says Evan Bauman of Legg Mason ClearBridge.

Health care, energy, and tech--where the big companies have the cash, and the mid- and small companies have a lot of growth--are ripe for continued M&A activity, says Legg Mason ClearBridge's Evan Bauman.